Ongoing drug shortages are forcing increased scrutiny around the power of federal regulators in supply chain management. Key drugs currently in shortage include cancer medications like cisplatin and carboplatin; a form of the common antibiotic amoxicillin; diabetes treatments like Ozempic, Mounjaro and Trulicity; as well as the common ADHD medication Adderall. Democrats and Republicans have…
The Food and Drug Administration (FDA) announced Wednesday the first leader of a new program dedicated to human foods, part of an agency-wide reorganization effort launched in the wake of a contaminated baby formula crisis last year. James Jones, a former official at the Environmental Protection Agency (EPA), will serve as the new deputy commissioner…
Lawmakers have penned a letter to the U.S. Food and Drug Administration (FDA) urging the agency to consult with Tribal Nations as it finalizes a new policy on at-home disposal of prescription opioids. In April, the FDA issued a policy in partnership with the United States Postal Service (USPS) that would require manufacturers of opioids dispensed in pharmacies to provide prepaid mail-back envelopes for patients to dispose of unused prescription pills. The policy is an effort to curb nonmedical opioid use and a response to the ongoing opioid epidemic.
The Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) on Tuesday laid out steps they are taking to mitigate the ongoing shortage of prescription stimulants like Adderall. Prescription stimulants, which are commonly used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy, have been in short supply since last fall, after a major drug maker…